MEDICATION ADDITION TEMPLATE (PharmDS)

This template defines the minimum information required when adding a new medication
to PharmDS. Not all fields are required for every drug. Leave fields blank if unknown
or intentionally out of scope.

--------------------------------------------------
BASIC IDENTIFICATION
--------------------------------------------------

Generic name:
Lowercase id (used internally, usually same as generic):

Brand names / aliases:
(list all common brand names or alternate spellings)

Drug class:
(e.g., SSRI, antipsychotic, benzodiazepine, antiarrhythmic)

Therapeutic index:
(narrow / moderate / wide / unknown)

Brief educational note:
(1â€“2 sentences explaining clinical relevance or why this drug is included)


--------------------------------------------------
PHARMACOKINETICS (PK)
--------------------------------------------------

CYP substrate roles:
- Enzyme:
- Strength (if known):
- Fraction metabolized (if known):
- Notes / uncertainty:

CYP inhibition:
- Enzyme(s):
- Strength (weak / moderate / strong):
- Notes / references:

CYP induction:
- Enzyme(s):
- Strength:
- Notes / references:

Transporter substrate roles:
- Transporter (e.g., P-gp, BCRP):
- Notes:

Transporter inhibition or induction:
- Transporter:
- Role (inhibitor / inducer):
- Strength:
- Notes / uncertainty:


--------------------------------------------------
PHARMACODYNAMICS (PD)
--------------------------------------------------

Relevant PD domains:
(check all that apply)

[ ] QT prolongation
[ ] Sedation / CNS depression
[ ] Serotonergic effects
[ ] Bleeding risk
[ ] Hypotension / bradycardia
[ ] Anticholinergic burden
[ ] Other (specify):

PD notes:
Brief explanation of why this drug belongs to the selected domains.


--------------------------------------------------
RULE INTERACTIONS
--------------------------------------------------

Existing rules this drug should trigger:
(list rule IDs and rationale)

Existing rules this drug should NOT trigger:
(list tempting false positives to guard against)

New rules required?
[ ] No
[ ] Yes (describe briefly)


--------------------------------------------------
TESTING REQUIREMENTS
--------------------------------------------------

Positive test(s) added:
- Drug pair:
- Expected rule_id(s):

Negative test(s) added:
- Drug pair:
- Rule(s) that should NOT fire:

Rationale for test selection:
(why these scenarios matter)


--------------------------------------------------
REFERENCES (OPTIONAL BUT ENCOURAGED)
--------------------------------------------------

Sources used:
- FDA label
- Review articles
- Trusted pharmacology references
- Educational summaries

Notes on variability or controversy:
(If data is inconsistent, explain how it was modeled conservatively)


--------------------------------------------------
CONTRIBUTOR ATTESTATION
--------------------------------------------------

[ ] This addition is educational in scope
[ ] I added or updated tests
[ ] I considered false positives and rule overreach
